People v. Bendovid

CourtCalifornia Court of Appeal
DecidedDecember 20, 2018
DocketB288633
StatusPublished

This text of People v. Bendovid (People v. Bendovid) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
People v. Bendovid, (Cal. Ct. App. 2018).

Opinion

Filed 12/20/18 CERTIFIED FOR PUBLICATION

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION SIX

THE PEOPLE, 2d Crim. No. B288633 (Super. Ct. No. 17PT-00942) Plaintiff and Respondent, (San Luis Obispo County)

v.

YOSEF SHAVUII BENDOVID,

Defendant and Appellant.

Mentally disordered offenders (MDO's) committed for treatment lose their freedom. Courts must ensure strict compliance with statutory requirements to guarantee that commitments are not arbitrary and comport with due process. Yosef Shavuii Bendovid appeals an order committing him for treatment as an MDO pursuant to Penal Code section 2962.1 We conclude, among other things, that Bendovid did not receive 90 days of treatment for his disorder “within the year” prior to his “parole or release.” (§ 2962, subd. (c).) We reverse.

1 All statutory references are to the Penal Code. FACTS In 2015, Bendovid was convicted of assault with force likely to produce great bodily injury (§ 245, subd. (a)(4)) and sentenced to two years in state prison. In August 2017, the Board of Parole Hearings (BPH) classified Bendovid as an MDO. (§ 2962.) On November 7, 2017, Bendovid challenged the BPH determination in court (§§ 2962, 2966, subd. (b)), and waived his right to a jury trial. Meghan Brannick, a forensic psychologist at Atascadero State Hospital (ASH), testified Bendovid has a “delusional disorder,” which qualifies as a severe mental disorder. His disorder was an “aggravating factor” in his commitment offense of assault, which he committed at a church where he was not a member of the congregation. His actions were “odd and unprovoked.” In committing the crime, he had the delusional belief that he was a “Prince of Israel.” His statements “made in subsequent e-mails” showed his “delusional thought processes.” Brannick testified Bendovid’s mental disorder is not in remission and “could not be kept in remission without treatment.” As of the date of the BPH hearing, Bendovid posed “a substantial risk of physical harm to others by reason of his severe mental disorder.” He has a history of “violent and aggressive behavior.” When she interviewed him, he showed a “limited insight into his disorder and need for treatment.” He has a history of “treatment noncompliance.” Bendovid first received treatment for his mood disorder in jail, and then in prison from June 5, 2017, to August 18, 2017. He was prescribed Risperdal and Depakote. Risperdal is an “antipsychotic medication” prescribed for “psychotic symptoms.”

2 His treatment in prison was not long enough to satisfy the 90-day treatment requirement. Brannick testified the jail medical records revealed that Bendovid was “suicidal” over his fear of being sent to prison. Bendovid was prescribed Abilify in jail. Abilify is an “antipsychotic medication with mood stabilizing benefits.” It was administered by shots “every four weeks,” beginning April 5, 2017, and ending May 21, 2017. Brannick testified this shows he was “undergoing treatment for a mental health issue” in jail. In jail Bendovid also received Depakene, the liquid form of Depakote. Depakene is “another mood stabilizing medication.” The People introduced the jail medical records, which reflect Bendovid was diagnosed for mood and personality disorders in jail, not for a delusional disorder. Brannick said the jail authorities and ASH diagnosed Bendovid with different disorders. Bendovid claimed the People could not prove 90 days of treatment because the jail authorities had not diagnosed him for his delusional disorder which was his severe mental disorder. Nevertheless, the trial court found Bendovid met the criteria for an MDO commitment. DISCUSSION 90 Days of Treatment Requirement Bendovid contends there is insufficient evidence that he received 90 days of treatment for his severe mental disorder. “ ‘ “To be substantial, the evidence must be ‘ “of ponderable legal significance . . . reasonable in nature, credible and of solid value.” ’ ” ’ ” (People v. Wright (2016) 4 Cal.App.5th 537, 545.) For an MDO commitment, the defendant must receive 90 days of treatment for his or her severe mental disorder “in the

3 year before being paroled.” (People v. Sheek (2004) 122 Cal.App.4th 1606, 1610; § 2962.) Proof that the defendant has a severe mental disorder that was not in remission and the other MDO factors in section 2962 will not authorize a commitment unless the People prove the 90-day treatment requirement. (Ibid.)2 Bendovid does not dispute that he received 75 days of treatment in prison. But he claims he did not receive treatment for his delusional disorder in jail before he was sent to prison. The People contend the trial court could reasonably find that he received at least 15 days of treatment for that disorder while in jail. But the prosecutor told the trial court that jail records show “there’s a diagnosis of unspecified mood disorder.” He did not claim there was a diagnosis for the delusional disorder in the jail records. The delusional disorder is the severe mental disorder in this case. The jail medical records, which the People introduced into evidence to prove treatment, show: 1) that on April 5, 2017, Bendovid was diagnosed with an “unspecified mood disorder” and

2 “An offender is eligible for commitment under the MDO Act if all of the following six factors are met: (1) the prisoner has a severe mental disorder; (2) the prisoner used force or violence in committing the underlying offense; (3) the prisoner had a disorder which caused or was an aggravating factor in committing the offense; (4) the disorder is not in remission or capable of being kept in remission in the absence of treatment; (5) the prisoner was treated for the disorder for at least 90 days in the year before being paroled; and (6) because of the disorder, the prisoner poses a serious threat of physical harm to other people.” (People v. Sheek, supra, 122 Cal.App.4th at p. 1610.)

4 an “unspecified personality disorder”; 2) he was treated for these disorders until May 20, 2017, in jail; 3) the final diagnosis was that he had those two disorders; and 4) the jail’s May 20, 2017, medical transfer document to state prison lists those same two diagnosed disorders. Bendovid notes the jail records do not show a diagnosis for a delusional disorder. The jail medical authorities did not state that they were treating him for such a disorder or that they saw evidence that he had delusions. “The MDO [Act] requires the district attorney to accept the diagnosis and prognosis of the physicians at the treating facility . . . .” (Cuccia v. Superior Court (2007) 153 Cal.App.4th 347, 355.) Here the relevant treating facility was the county jail. The People concede that the jail medical authorities did not diagnose Bendovid as having a “delusional disorder.” The diagnosis for that disorder occurred later. Brannick said Bendovid “started treatment on June 5, 2017” for his delusional disorder in prison. He received treatment there until August 18, 2017. But that prison treatment period is less than 90 days. Brannick acknowledged that the jail, prison and ASH medical authorities had made different diagnoses of Bendovid’s mental disorders. She said, “[T]he diagnosis that’s best identified at the San Diego Sheriff’s Department, I don’t believe needs to be consistent with [the] diagnosis we’ve rendered at [ASH].” (Italics added.) But the different diagnoses meant Bendovid was being diagnosed and treated for a different disorder in prison than the two disorders he was diagnosed and treated for in jail. To establish treatment for the 90-day requirement, the People must prove the defendant “was diagnosed” for the severe mental

5 disorder during the relevant treatment period. (People v. Sheek, supra, 122 Cal.App.4th at p.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kansas v. Crane
534 U.S. 407 (Supreme Court, 2002)
United States v. Ruiz-Gaxiola
623 F.3d 684 (Ninth Circuit, 2010)
In Re Jerome Curry, Patient
452 F.2d 1360 (D.C. Circuit, 1971)
United States v. Hessam Ghane
392 F.3d 317 (Eighth Circuit, 2004)
United States v. Bush
585 F.3d 806 (Fourth Circuit, 2009)
People v. Alkow
218 P.2d 607 (California Court of Appeal, 1950)
Scarborough v. Aetna Life Insurance Co.
572 S.W.2d 282 (Texas Supreme Court, 1978)
Van Volkenburg v. Continental Casualty Insurance
971 F. Supp. 117 (W.D. New York, 1997)
Gunn v. Employment Development Dept.
94 Cal. App. 3d 658 (California Court of Appeal, 1979)
Craig v. Central National Life Insurance
148 N.E.2d 31 (Appellate Court of Illinois, 1958)
Cuccia v. Superior Court
62 Cal. Rptr. 3d 796 (California Court of Appeal, 2007)
Bushling v. Fremont Medical Center
11 Cal. Rptr. 3d 653 (California Court of Appeal, 2004)
People v. Anthony C.
42 Cal. Rptr. 3d 370 (California Court of Appeal, 2006)
People v. Garcia
25 Cal. Rptr. 3d 660 (California Court of Appeal, 2005)
People v. Sheek
19 Cal. Rptr. 3d 737 (California Court of Appeal, 2004)
People v. Robinson
84 Cal. Rptr. 2d 832 (California Court of Appeal, 1999)
Miskovitch v. Hostoffer
721 F. Supp. 2d 389 (W.D. Pennsylvania, 2010)
Loper v. Morrison
145 P.2d 1 (California Supreme Court, 1944)
United States v. Charles Gillenwater, II
749 F.3d 1094 (Ninth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
People v. Bendovid, Counsel Stack Legal Research, https://law.counselstack.com/opinion/people-v-bendovid-calctapp-2018.